Even as more and more industries are readily embracing data-driven digital marketing, pharmaceutical companies have been noticeably slow in embracing such opportunities.
Two considerations – largely unique to pharma marketing – help account for this tardiness:
- Regulation: Life-sciences organizations must comply with specific federal and state reporting and compliance requirements. Additionally, the US Food and Drug Administration has strict guidelines about promoting pharmaceuticals on both new and old media.
- Data: Pharma companies are stalled by too much, rather than too little, information. An enormous variety of information sources – ranging from anonymous patient data to retail sales –...